Hungary Richter spends nearly HUF 5 billion on new lab

In Debrecen

Richter to expand use of its drug for therapeutic purposes

For women suffering from endometriosis

Hungary Richter divests Romanian subsidiary

Wholesale and retail too

Hungary Richter signs deal on distribution of Evra in Canada

With Searchlight Pharma Inc.

Richter posts record quarterly revenue, profit, faces uncertainties in Russia, Ukraine

Robost performance in Q4 2021

Richter to enter U.S. market with new drug

Signs license agreement with Hikma

Hungary Richter keeps breaking records

Revenue and after-tax profit at never-before-seen levels in Q3

Hungary’s Richter decides on mandatory vaccination

Management ups guidance after strong Q3

National Asset Management influence in Richter ceases

Transferred to National health and Education of Medical Doctors

Hungary’s Richter surprises analysts with record Q2 result (3)

BUX index of Budapest Stock Exchange hits another high in July

Wood remains top brokerage

European Commission greenlights new Richter drug

Ryeqq granted marketing authorisation

Wood tops BSE brokerage ranking for sixth month in a row

BUX index reaches another record high in June

Richter sells wholesale, retail operations in Moldova

Will receive 62% of price as majority owner

Hungary Richter issues HUF 70 bn bond

In scope of central bank programme

Hungary’s Richter extends licensing agreement with AbbVie

Cariprazine to be sold in more countries

Hungary Richter to issue up to HUF 70 billion worth of bonds

It would be one of the largest issuances in the central bank's programme

EMA recommends approval of new drug of Hungary's Richter

Final call on authorisation can be expected in two months

Hungary’s Richter gains EC approval for new drug

Oral contraceptive to be marketed in Europe

Hungary Richter shares dividend payment details

Key dates published